Physician profile
Chris Pardue
NPI 1841369675
$1,611.97
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,223 · 2020: $335 · 2021: $35.60 · 2022: $19.31.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $417.86 | 2019-2020 | |
| Lilly USA, LLC | $136.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $134.10 | 2019-2020 | |
| Janssen Biotech, INC. | $132.21 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $119.93 | 2019-2020 | |
| Merz North America, INC. | $83.59 | 2019-2020 | |
| Epi Health, LLC | $76.36 | 2019-2020 | |
| Genzyme Corporation | $60.41 | 2019-2020 | |
| Ucb, INC. | $59.40 | 2019 | |
| Pfizer INC. | $44.86 | 2019-2020 | |
| Genentech USA, INC. | $44.63 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.68 | 2019 | |
| Biofrontera INC. | $39.25 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $37.82 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $34.69 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $27.02 | 2019 | |
| Dermira, INC. | $22.49 | 2019 | |
| Almirall LLC | $19.44 | 2019 | |
| Sandoz INC. | $18.13 | 2019 | |
| Allergan, INC. | $18.10 | 2019 | |
| Amgen INC. | $15.84 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $14.61 | 2019 | |
| Galderma Laboratories, L.P. | $10.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Pardue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.